SG140147A1 - Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof - Google Patents
Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereofInfo
- Publication number
- SG140147A1 SG140147A1 SG200801326A SG200801326A SG140147A1 SG 140147 A1 SG140147 A1 SG 140147A1 SG 200801326 A SG200801326 A SG 200801326A SG 200801326 A SG200801326 A SG 200801326A SG 140147 A1 SG140147 A1 SG 140147A1
- Authority
- SG
- Singapore
- Prior art keywords
- combination
- therapeutic application
- heteroaryl compound
- substituted bis
- hypnotic agent
- Prior art date
Links
- 125000003118 aryl group Chemical group 0.000 title 1
- -1 heteroaryl compound Chemical class 0.000 title 1
- 239000003326 hypnotic agent Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70965505P | 2005-08-19 | 2005-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG140147A1 true SG140147A1 (en) | 2008-03-28 |
Family
ID=37772166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200801326A SG140147A1 (en) | 2005-08-19 | 2006-08-16 | Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7618650B2 (es) |
| EP (1) | EP1928442B1 (es) |
| JP (1) | JP2009504761A (es) |
| KR (1) | KR20080038416A (es) |
| CN (1) | CN101242819A (es) |
| AR (1) | AR055609A1 (es) |
| AT (1) | ATE447400T1 (es) |
| AU (1) | AU2006283703A1 (es) |
| BR (1) | BRPI0614943A2 (es) |
| CA (1) | CA2617980A1 (es) |
| DE (1) | DE602006010219D1 (es) |
| ES (1) | ES2336142T3 (es) |
| MX (1) | MX2008001778A (es) |
| RU (1) | RU2008110498A (es) |
| SG (1) | SG140147A1 (es) |
| TW (1) | TW200815009A (es) |
| WO (1) | WO2007024600A2 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2889811B1 (fr) * | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| BRPI0520797B8 (pt) * | 2005-11-18 | 2021-05-25 | Accu Break Tech Inc | forma de dosagem farmacêutica comprimida em bicamadas |
| JP2012505892A (ja) | 2008-10-15 | 2012-03-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｍｍｐ−１３阻害剤として有用な縮合ヘテロアリールジアミド化合物 |
| CA2738929A1 (en) | 2008-10-17 | 2010-04-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| CN102018681A (zh) * | 2010-12-10 | 2011-04-20 | 荣港生技医药科技（北京）有限公司 | 一种美乐托宁缓释剂、其制备方法及其应用 |
| US20130060052A1 (en) * | 2011-01-17 | 2013-03-07 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
| US9120757B2 (en) | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| BR112015022785A2 (pt) | 2013-03-14 | 2017-07-18 | Epizyme Inc | composto; composição farmacêutica; kit ou artigo farmacêutico embalado; método de inibição de uma arginina metil transferase (rmt); método de modulação da expressão genética; método de modulação da transcrição; e método de tratamento de um distúrbio mediado por rmt |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ334868A (en) * | 1996-10-21 | 2001-02-23 | Neurosearch As | 1-Phenyl-benzimidazole compounds and their use as BAGA-a receptor modulators |
| US20040258750A1 (en) * | 1999-06-28 | 2004-12-23 | Gerard Alaux | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| AU5721301A (en) * | 2000-04-24 | 2001-11-07 | Teva Pharma | Zolpidem hemitartrate |
| GT200600042A (es) * | 2005-02-10 | 2006-09-27 | Aventis Pharma Inc | Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a |
-
2006
- 2006-08-16 AU AU2006283703A patent/AU2006283703A1/en not_active Abandoned
- 2006-08-16 WO PCT/US2006/032027 patent/WO2007024600A2/en active Application Filing
- 2006-08-16 RU RU2008110498/04A patent/RU2008110498A/ru not_active Application Discontinuation
- 2006-08-16 KR KR1020087006619A patent/KR20080038416A/ko not_active Application Discontinuation
- 2006-08-16 EP EP06789813A patent/EP1928442B1/en active Active
- 2006-08-16 AT AT06789813T patent/ATE447400T1/de not_active IP Right Cessation
- 2006-08-16 JP JP2008527115A patent/JP2009504761A/ja active Pending
- 2006-08-16 BR BRPI0614943-0A patent/BRPI0614943A2/pt not_active IP Right Cessation
- 2006-08-16 ES ES06789813T patent/ES2336142T3/es active Active
- 2006-08-16 MX MX2008001778A patent/MX2008001778A/es not_active Application Discontinuation
- 2006-08-16 CN CNA2006800296536A patent/CN101242819A/zh active Pending
- 2006-08-16 SG SG200801326A patent/SG140147A1/en unknown
- 2006-08-16 DE DE602006010219T patent/DE602006010219D1/de active Active
- 2006-08-16 CA CA002617980A patent/CA2617980A1/en not_active Abandoned
- 2006-08-17 AR ARP060103594A patent/AR055609A1/es unknown
- 2006-08-18 TW TW095130323A patent/TW200815009A/zh unknown
-
2008
- 2008-02-06 US US12/027,022 patent/US7618650B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2617980A1 (en) | 2007-03-01 |
| TW200815009A (en) | 2008-04-01 |
| US20080138413A1 (en) | 2008-06-12 |
| ES2336142T3 (es) | 2010-04-08 |
| KR20080038416A (ko) | 2008-05-06 |
| ATE447400T1 (de) | 2009-11-15 |
| WO2007024600A3 (en) | 2007-05-24 |
| CN101242819A (zh) | 2008-08-13 |
| MX2008001778A (es) | 2008-04-07 |
| DE602006010219D1 (de) | 2009-12-17 |
| EP1928442A2 (en) | 2008-06-11 |
| RU2008110498A (ru) | 2009-09-27 |
| AU2006283703A1 (en) | 2007-03-01 |
| AR055609A1 (es) | 2007-08-29 |
| JP2009504761A (ja) | 2009-02-05 |
| WO2007024600A2 (en) | 2007-03-01 |
| US7618650B2 (en) | 2009-11-17 |
| EP1928442B1 (en) | 2009-11-04 |
| BRPI0614943A2 (pt) | 2011-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258903A1 (zh) | 抗-連接蛋白化合物及其治療應用 | |
| HK1199874A1 (en) | Spiro-oxindole compounds and their uses as therapeutic agents | |
| AP2006003769A0 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| SG140147A1 (en) | Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof | |
| IL178969A0 (en) | Fungicidal mixtures of amidinylphenyl compounds | |
| IL178676A0 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| EP1833482A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
| HK1083341A1 (en) | Stable crystal of 4-oxoquinoline compound | |
| IL190293A0 (en) | Nitrogen-containing heterocyclic compound and pharmaceutical application thereof | |
| IL186615A0 (en) | Spiroheterocylic compounds and their uses as therapeutic agents | |
| IL191035A0 (en) | Pharmaceutical use of substituted amides | |
| IL191034A0 (en) | Pharmaceutical use of substituted amides | |
| IL209964A0 (en) | Use of organic compounds | |
| GB0504995D0 (en) | Use of a compound | |
| EP1776112A4 (en) | HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS | |
| GB0524428D0 (en) | Medicinal use of receptor ligands | |
| IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
| HK1133886A1 (en) | Substituted aryl-indole compounds and their kynurenine kynuramine-like metabolites as therapeutic agents | |
| IL190226A0 (en) | Organometallic compounds and methods of use thereof | |
| PL1740204T3 (pl) | Lecznicze zastosowanie alfa-mannozydazy | |
| GB0410470D0 (en) | Pharmaceutical compound and polymorphs thereof | |
| ZA200705561B (en) | Stabilisation of radiopharmaceutical precursors | |
| EP1852432A4 (en) | NITROGENIC HETEROCYCLIC COMPOUND AND THEIR MEDICAL USE | |
| FR2873294B1 (fr) | Association de medicaments | |
| HK1120408A1 (en) | Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |